Fig. 2From: Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative studyComparison of the death rate (per 100,000 population) due to COVID-19 and the number of drugs being developed for COVID-19 by region (as of June 21, 2020). *The size of the circle indicates the proportion of the drugs being developed in totalBack to article page